ArticleHealthcare (Basel, Switzerland)2024

Efficacy and Safety of Bojungikgi-Tang for Persistent Allergic Rhinitis: A Randomized, Double-Blinded, Placebo-Controlled, Phase II Trial.

Su Won Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.